Organizations:

MDS Inc's R&D outlays and revenue decline

Guest Contributor
September 22, 2009

MDS Inc's third quarter financial results show substantial declines in overall revenue and R&D spending as the firm continues to divest many of its business units. For the three months ending July 31st, the Toronto-based firm registered revenue of $192 million down 21% from $244 million in the same period last year. R&D also declined from $19 million to $16 million in the most recent quarter. Nine-month R&D totaled $44 million compared to $61 million in the same period last year. Following the release of its financials, MDS announced a change in its CEO (see People column on this page)….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.